Olanzapine long-acting injection, discontinuation rates and reasons for discontinuation: 10 years’ experience at a UK high-secure hospital

BACKGROUND: Olanzapine pamoate has been shown to be an effective second-generation long-acting injection. Its popularity has possibly been adversely affected by the rare incidence of post-injection syndrome (PIS) and the associated requirement to monitor for 3 h after each injection. OBJECTIVE: This...

Descripción completa

Detalles Bibliográficos
Autores principales: Attard, Azizah, Wakelam, John, Broyd, Josephine, Taylor, David, Hafferty, Jonathan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9301109/
https://www.ncbi.nlm.nih.gov/pubmed/35874556
http://dx.doi.org/10.1177/20451253221113093

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9301109/
https://www.ncbi.nlm.nih.gov/pubmed/35874556
http://dx.doi.org/10.1177/20451253221113093

Ejemplares similares